decreased alpha-beta T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
decreased Ly6C-positive mature NK cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
decreased memory-marker CD4-positive NK T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
decreased T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
decreased regulatory T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
decreased CD5-positive gamma-delta T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
increased NK cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
increased CD4-negative NK T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
decreased circulating calcium level
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
5.56×10-06
|
female infertility
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
abnormal ulna morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
3.82×10-17
|
increased circulating sodium level
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
1.27×10-07
|
decreased early germinal center B cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
obsolete decreased CD4-positive, alpha beta T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
decreased NK cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
increased circulating alkaline phosphatase level
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
4.18×10-25
|
increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
increased memory-marker gamma-delta T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
abnormal radius morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
1.05×10-16
|
abnormal pelvic girdle bone morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
1.51×10-13
|
abnormal femur morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
3.82×10-17
|
increased bone mineral content
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
1.90×10-07
|
decreased circulating potassium level
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
2.17×10-08
|
decreased memory-marker CD4-negative NK T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
decreased KLRG1-positive NK cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
abnormal cornea morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
3.41×10-05
|
decreased circulating cholesterol level
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
8.60×10-06
|
decreased circulating fructosamine level
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
6.48×10-07
|
decreased circulating glucose level
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
2.14×10-24
|
increased follicular B cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
decreased KLRG1-positive T-helper cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
abnormal tail morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
1.52×10-16
|
increased eosinophil cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
abnormal spine curvature
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
2.50×10-11
|
increased effector memory T-helper cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
abnormal coat/hair pigmentation
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
1.05×10-11
|
decreased effector memory T-helper cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
increased Ly6C-positive NK T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
increased red blood cell distribution width
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
8.69×10-07
|
abnormal humerus morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
2.51×10-18
|
abnormal vertebrae morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
2.21×10-10
|
increased memory-marker NK cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
increased mean corpuscular hemoglobin
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
3.21×10-12
|
increased heart weight
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
4.48×10-05
|
abnormal cranium morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
2.11×10-12
|
abnormal rib morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
2.55×10-07
|
abnormal thoracic cage shape
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
6.18×10-15
|
increased KLRG1+ CD8 alpha beta T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
decreased erythrocyte cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
1.93×10-09
|
abnormal zygomatic bone morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
1.89×10-05
|
decreased CD4-positive, alpha beta T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
abnormal bone structure
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
7.18×10-06
|
decreased circulating glycerol level
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
1.09×10-06
|
increased plasmacytoid dendritic cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
abnormal joint morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
5.46×10-16
|
thrombocytopenia
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
2.45×10-05
|
increased circulating bilirubin level
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
8.33×10-06
|
decreased circulating insulin level
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
4.67×10-16
|
decreased CD4-positive NK T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
decreased circulating triglyceride level
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
1.11×10-12
|
decreased circulating free fatty acid level
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
3.71×10-05
|
decreased gamma-delta T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
decreased circulating HDL cholesterol level
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
4.44×10-05
|
increased CD8-positive, naive alpha-beta T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
abnormal tibia morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
3.18×10-19
|
decreased NK T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
increased KLRG1-positive CD4-negative NK T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
increased CD8-positive, alpha-beta T cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
improved glucose tolerance
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
5.34×10-25
|
decreased T-helper cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
increased KLRG1-positive T-helper cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
abnormal retina morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
4.58×10-05
|
decreased blood urea nitrogen level
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
9.89×10-08
|
increased granulocyte number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
decreased total body fat amount
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
4.48×10-26
|
increased lean body mass
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
8.83×10-17
|
kyphosis
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
2.71×10-10
|
decreased germinal center B cell number
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
0.00
|
abnormal fibula morphology
|
|
Sik3tm1a(EUCOMM)Hmgu
|
HOM
|
|
Early adult
|
3.18×10-19
|